Original Source(s)
Related Content
FDA Approves Melanoma BRAF Companion Test
The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.
August 10, 2026
-
1 min
Cancer Detection: The e-Nose Knows
Emerging e-nose technology analyzes chemical signatures from breath and skin to support cancer diagnosis
August 3, 2026
-
3 min
Cyclospora Alert Spurs US Testing Focus
CDC links multistate outbreak to recalled iceberg lettuce, highlighting the need for targeted laboratory testing
August 13, 2026
-
2 min
